CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates cancer cachexia, a syndrome causing severe weight loss in cancer patients. It explores specific gene pathways in muscle tissue to identify potential treatments and examines the role of exercise-induced molecules that may protect against cancer progression.
Cancer cachexia is a life-threatening syndrome characterized by severe body weight loss, due to depletion of adipose tissue and skeletal muscle, and affects up to 80% of patients with advanced cancers.
The rapid loss of muscle mass is the main cause of function impairment, fatigue and respiratory complications, leading to death in 20-48% of cases.
To date, no effective treatment is available.
By using Ingenuity Pathways Analysis software, I have analyzed the cancer cachexia-specific genes, found…
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Roma
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
